MALARONE - 0173-0676-01 - (atovaquone and proguanil hydrochloride)

Alphabetical Index


Drug Information of MALARONE

Product NDC: 0173-0676
Proprietary Name: MALARONE
Non Proprietary Name: atovaquone and proguanil hydrochloride
Active Ingredient(s): 62.5; 25    mg/1; mg/1 & nbsp;   atovaquone and proguanil hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of MALARONE

Product NDC: 0173-0676
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021078
Marketing Category: NDA
Start Marketing Date: 20000726

Package Information of MALARONE

Package NDC: 0173-0676-01
Package Description: 100 TABLET, FILM COATED in 1 BOTTLE (0173-0676-01)

NDC Information of MALARONE

NDC Code 0173-0676-01
Proprietary Name MALARONE
Package Description 100 TABLET, FILM COATED in 1 BOTTLE (0173-0676-01)
Product NDC 0173-0676
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name atovaquone and proguanil hydrochloride
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20000726
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name ATOVAQUONE; PROGUANIL HYDROCHLORIDE
Strength Number 62.5; 25
Strength Unit mg/1; mg/1
Pharmaceutical Classes Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA]

Complete Information of MALARONE


General Information